- Home
- MIST vs MHH Comparison
MIST vs MHH Comparison
Compare MIST & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- MHH
- Stock Information
- Founded
- MIST 2003
- MHH 1986
- Country
- MIST Canada
- MHH United States
- Employees
- MIST N/A
- MHH N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- MHH Professional Services
- Sector
- MIST Health Care
- MHH Consumer Discretionary
- Exchange
- MIST Nasdaq
- MHH Nasdaq
- Market Cap
- MIST 53.9M
- MHH N/A
- IPO Year
- MIST N/A
- MHH N/A
- Fundamental
- Price
- MIST $1.11
- MHH $7.89
- Analyst Decision
- MIST Strong Buy
- MHH
- Analyst Count
- MIST 2
- MHH 0
- Target Price
- MIST $9.50
- MHH N/A
- AVG Volume (30 Days)
- MIST 1.6M
- MHH 15.0K
- Earning Date
- MIST 05-20-2025
- MHH 05-16-2025
- Dividend Yield
- MIST N/A
- MHH N/A
- EPS Growth
- MIST N/A
- MHH N/A
- EPS
- MIST N/A
- MHH 0.28
- Revenue
- MIST N/A
- MHH $198,943,000.00
- Revenue This Year
- MIST N/A
- MHH $1.22
- Revenue Next Year
- MIST N/A
- MHH $5.41
- P/E Ratio
- MIST N/A
- MHH $27.57
- Revenue Growth
- MIST N/A
- MHH N/A
- 52 Week Low
- MIST $0.63
- MHH $7.15
- 52 Week High
- MIST $2.75
- MHH $16.00
- Technical
- Relative Strength Index (RSI)
- MIST 43.96
- MHH 45.75
- Support Level
- MIST $1.28
- MHH $7.30
- Resistance Level
- MIST $1.32
- MHH $8.38
- Average True Range (ATR)
- MIST 0.12
- MHH 0.53
- MACD
- MIST 0.02
- MHH 0.14
- Stochastic Oscillator
- MIST 27.39
- MHH 52.94
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).